Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE OF CHINA BCT PHARMACY GROUP, INC. DATED MAY 21, 2010 - China BCT Pharmacy Group, Inc. | f8k052110ex99i_chinabct.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934
Date of Report (date of earliest event reported): May 21, 2010
CHINA BCT PHARMACY GROUP, INC.
(Exact name of registrant as specified in charter)
|
Delaware
|
033-145620
|
20-8067060
|
|
(State of Incorporation)
|
(Commission File No.)
|
(IRS Employer
Identification No.)
|
No. 102 Chengzhan Road
Liuzhou City, Guanxi Province
545007 PRChina
(Address Of Principal Executive Offices) (Zip Code)
(011) 86-(772) 363 8318
(Registrant’s Telephone Number, Including Area Code)
CHINA BAICAOTANG MEDICINE LIMTED, INC.
(Former Name or Former Address, is Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 2.02 Results of Operations and Financial Condition..
On May 21, 2010 China BCT Pharmacy Group, Inc. issued a press release regarding its financial results for the three months ended March 31, 2010. A copy of the press release is filed herewith as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
As provided in General Instruction B.2 of SEC Form 8-K, such information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and it shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or under the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description |
| 99.1 | Press Release of China BCT Pharmacy Group, Inc. dated May 21, 2010 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CHINA BCT PHARMACY GROUP, INC
By: /s/ Hui Tian Tang
Name: Hui Tian Tang
Title: Chief Executive Officer
Dated: May 24, 2010
3
Exhibit Index
|
Exhibit No.
|
Description
|
|
99.1
|
Press Release of China BCT Pharmacy Group, Inc. dated May 21, 2010
|
4